Amarin Corporation plc

NasdaqCM:AMRN Stock Report

Market Cap: US$240.0m

Amarin Past Earnings Performance

Past criteria checks 0/6

Amarin's earnings have been declining at an average annual rate of -31.9%, while the Biotechs industry saw earnings growing at 15.2% annually. Revenues have been declining at an average rate of 20.4% per year.

Key information

-31.87%

Earnings growth rate

-30.49%

EPS growth rate

Biotechs Industry Growth17.04%
Revenue growth rate-20.37%
Return on equity-18.56%
Net Margin-41.07%
Last Earnings Update31 Mar 2025

Recent past performance updates

Recent updates

author-image

I Foresee 49 Approvals Driving European And Global Market Expansion

Expanded regulatory approvals and commercialization in 49 markets support future revenue growth, particularly through focused expansion in Europe and worldwide.

The Market Doesn't Like What It Sees From Amarin Corporation plc's (NASDAQ:AMRN) Revenues Yet As Shares Tumble 26%

Mar 15
The Market Doesn't Like What It Sees From Amarin Corporation plc's (NASDAQ:AMRN) Revenues Yet As Shares Tumble 26%

Amarin Corporation plc (NASDAQ:AMRN) Held Back By Insufficient Growth Even After Shares Climb 39%

Jan 24
Amarin Corporation plc (NASDAQ:AMRN) Held Back By Insufficient Growth Even After Shares Climb 39%

Here's Why We're Not Too Worried About Amarin's (NASDAQ:AMRN) Cash Burn Situation

Jan 03
Here's Why We're Not Too Worried About Amarin's (NASDAQ:AMRN) Cash Burn Situation

Little Excitement Around Amarin Corporation plc's (NASDAQ:AMRN) Revenues

Oct 29
Little Excitement Around Amarin Corporation plc's (NASDAQ:AMRN) Revenues

Amarin Corporation plc (NASDAQ:AMRN) Shares Could Be 29% Above Their Intrinsic Value Estimate

Aug 01
Amarin Corporation plc (NASDAQ:AMRN) Shares Could Be 29% Above Their Intrinsic Value Estimate

Amarin Corporation plc's (NASDAQ:AMRN) 28% Dip In Price Shows Sentiment Is Matching Revenues

Jun 06
Amarin Corporation plc's (NASDAQ:AMRN) 28% Dip In Price Shows Sentiment Is Matching Revenues

Amarin Corporation: Small Signs Of Recovery May Not Be Enough

Apr 16

Little Excitement Around Amarin Corporation plc's (NASDAQ:AMRN) Revenues As Shares Take 27% Pounding

Mar 12
Little Excitement Around Amarin Corporation plc's (NASDAQ:AMRN) Revenues As Shares Take 27% Pounding

Amarin: Sarissa Is Giving Me Hope Again

Jan 15

Improved Revenues Required Before Amarin Corporation plc (NASDAQ:AMRN) Stock's 26% Jump Looks Justified

Jan 03
Improved Revenues Required Before Amarin Corporation plc (NASDAQ:AMRN) Stock's 26% Jump Looks Justified

Calculating The Fair Value Of Amarin Corporation plc (NASDAQ:AMRN)

Nov 19
Calculating The Fair Value Of Amarin Corporation plc (NASDAQ:AMRN)

Investors Don't See Light At End Of Amarin Corporation plc's (NASDAQ:AMRN) Tunnel

Sep 27
Investors Don't See Light At End Of Amarin Corporation plc's (NASDAQ:AMRN) Tunnel

We Think Amarin (NASDAQ:AMRN) Can Afford To Drive Business Growth

Jul 18
We Think Amarin (NASDAQ:AMRN) Can Afford To Drive Business Growth

Revenue & Expenses Breakdown

How Amarin makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NasdaqCM:AMRN Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 25214-8814921
31 Dec 24229-8215221
30 Sep 24241-3915921
30 Jun 24265-3416821
31 Mar 24277-5318022
31 Dec 23307-5920022
30 Sep 23322-5222422
30 Jun 23346-3823722
31 Mar 23361-9127326
31 Dec 22369-10630430
30 Sep 22423-9232931
30 Jun 22476-10037333
31 Mar 22536-2239330
31 Dec 21583840829
30 Sep 21606-243332
30 Jun 21620445034
31 Mar 21601143538
31 Dec 20614-1846339
30 Sep 20590-1644342
30 Jun 20546-1340540
31 Mar 20511-1938637
31 Dec 19430-2332434
30 Sep 19364-6330735
30 Jun 19307-8427540
31 Mar 19259-11725551
31 Dec 18229-11622756
30 Sep 18206-10518356
30 Jun 18198-9216653
31 Mar 18190-7114448
31 Dec 17181-6813547
30 Sep 17166-7313045
30 Jun 17151-7812348
31 Mar 17139-7811847
31 Dec 16130-8611150
30 Sep 16118-8110453
30 Jun 16107-9710453
31 Mar 1691-14710452
31 Dec 1582-14910151
30 Sep 1572-1479650
30 Jun 1564-1418852
31 Mar 1559-628451
31 Dec 1454-567950
30 Sep 1448-528152
30 Jun 1442-759055

Quality Earnings: AMRN is currently unprofitable.

Growing Profit Margin: AMRN is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: AMRN is unprofitable, and losses have increased over the past 5 years at a rate of 31.9% per year.

Accelerating Growth: Unable to compare AMRN's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AMRN is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (21.7%).

Return on Equity

High ROE: AMRN has a negative Return on Equity (-18.56%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/02 15:07
End of Day Share Price 2025/05/30 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Amarin Corporation plc is covered by 23 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ritu BaralCanaccord Genuity
Andrew FeinChardan Capital Markets, LLC
John BorisCitigroup Inc